Sensorion Share Price Deutsche Boerse AG
Stocks
RFM
FR0012596468
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2490 EUR | +1.84% |
|
+4.62% | -14.14% |
| Market Cap | 15Cr 17Cr 14Cr 13Cr 24Cr 1.66TCr 25Cr 164.98Cr 65Cr 829.33Cr 65Cr 64Cr 2.77TCr | P/E 2026 * |
-39x | P/E 2027 * | -6.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.86Cr 2.14Cr 1.74Cr 1.59Cr 2.99Cr 204.16Cr 3.04Cr 20Cr 7.98Cr 102.21Cr 8.04Cr 7.87Cr 341.1Cr | EV / Sales 2026 * |
0.85x | EV / Sales 2027 * | 23.5x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.84% | ||
| 1 week | +4.62% | ||
| Current month | +4.62% | ||
| 1 month | +16.08% | ||
| 3 months | -31.40% | ||
| 6 months | -6.74% | ||
| Current year | -14.14% |
| 1 week | 0.24 |  | 0.25 |
| 1 month | 0.21 | | 0.26 |
| Current year | 0.19 | | 0.65 |
| 1 year | 0.19 | | 0.65 |
| 3 years | 0.12 | | 0.98 |
| 5 years | 0.12 | | 2.24 |
| 10 years | 0.12 | | 2.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.84% | +4.62% | - | - | 17Cr | |
| +1.29% | +3.09% | +6.43% | +18.53% | 4.95TCr | |
| +0.89% | +10.37% | +491.34% | +598.75% | 4.4TCr | |
| +3.08% | +13.60% | +24.57% | +78.98% | 3.96TCr | |
| +1.38% | +2.97% | +34.54% | +10.66% | 3.93TCr | |
| +0.85% | +7.66% | +21.22% | +48.78% | 3.24TCr | |
| +0.08% | +4.80% | - | - | 1.68TCr | |
| +1.99% | +4.39% | +38.70% | +126.93% | 1.65TCr | |
| +0.34% | +2.76% | +5.39% | +20.43% | 1.4TCr | |
| +3.56% | +19.13% | +86.23% | +28.36% | 1.28TCr | |
| Average | +1.53% | +7.32% | +88.55% | +116.43% | 2.94TCr | |
| Weighted average by Cap. | +1.48% | +7.06% | +107.88% | +141.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.19Cr 2.52Cr 2.04Cr 1.87Cr 3.52Cr 240.5Cr 3.58Cr 24Cr 9.4Cr 120.4Cr 9.47Cr 9.27Cr 401.81Cr | 63.95L 73.82L 59.8L 54.65L 1.03Cr 70Cr 1.05Cr 7.01Cr 2.75Cr 35Cr 2.77Cr 2.71Cr 117.56Cr |
| Net income | -2L -3L -2L -2L -4L -2.6Cr -4L -25.93L -10.17L -1.3Cr -10.26L -10.03L -4.35Cr | -3.61Cr -4.17Cr -3.38Cr -3.09Cr -5.81Cr -397.42Cr -5.91Cr -40Cr -16Cr -198.97Cr -16Cr -15Cr -663.99Cr |
| Net Debt | -13Cr -15Cr -12Cr -11Cr -21Cr -1.45TCr -22Cr -144.65Cr -57Cr -727.12Cr -57Cr -56Cr -2.43TCr | - |
| Date | Price | Change |
|---|---|---|
| 10/26/10 | €0.2490 | +1.84% |
| 07/26/07 | €0.2445 | -3.36% |
| 06/26/06 | €0.2530 | +1.40% |
| 05/26/05 | €0.2495 | +4.83% |
| 04/26/04 | €0.2380 | -3.45% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
- RFM Stock
Select your edition
All financial news and data tailored to specific country editions
